Clinical trial NCT04530851: Compare Outcome of Enhanced Recovery After Cesarean Surgery and Conventional Care
Official title: Compare Outcome of Enhanced Recovery After Cesarean Surgery and Conventional Care in Rajavithi Hospital
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: To Determine Whether ERAS Can Reduce Length of Stay in Pregnant Women After Cesarean Section
Keywords: ERAS
Cesarean section
Length of stay
Lead sponsor: Department of Medical Services Ministry of Public Health of Thailand
Sponsor class: OTHER_GOV
First posted: 2020-08-28
Enrollment: 80
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Research objective to compare outcome(Length of stay, pain score, opioid drug use, Bowel function and complication ) of ERAS protocol and conventional care in pregnant women after elective cesarean section in Rajavithi hospital.

Detailed description: Research design is Randomized control trial. The pregnant women who go to elective cesarean section don't know the allocation. The group of ERAS protocol was separated from Conventional care in patient care unit.

The Pregnant are randomly in two group. In the ERAS group the pregnant receive the the intervention for preoperative care(Counselin, H2- antagonist and metroclopramide for prevent aspiration, Drink clear liquid until 2 hour before surgery), Intraoperative care (first generation cephalosporin in 60 minute before surgery, Clorhexidine for skin cleansing and Povidine for vaginal cleansing, regional anesthesia, keep warming, blunt expansion of uterine incision, do not peritoneal suture and subcuticular suture if less than 2 cm, local wound anesthesia.), post operative care ( Paracetamol and NSAIDs for for pain control, early remove catheter and ambulation, 5-HT3 antagonist for prevent nausea)

Eligibility criteria: Inclusion Criteria:

* Pregnant women who scheduled for elective Cesarean section at Rajavithi Hospital

Exclusion Criteria:

* Pregnant women who has preeclampsia with severe feature
* Pregnant women who has diabetes mellitus with uncontrolled blood sugar
* Pregnant women who has blood loss \> 1,500 ml after surgery
* Pregnant women who has chrioamnionitis.
* Pregnant women who has severe medical disease
* Pregnant women who has BMI \>= 40 kg/m2
* Pregnant women who has placenta adherence.

Primary outcomes:
measure: Compare length of stay of pregnant women after Cesarean section between ERAS protocol and conventional care
timeFrame: 1 year
Secondary outcomes:
measure: Compare pain of pregnant women after Cesarean section between ERAS protocol and conventional care
timeFrame: 1 year
measure: Compare opioid use of pregnant women after Cesarean section between ERAS protocol and conventional care
timeFrame: 1 year
measure: Compare complication of pregnant women after Cesarean section between ERAS protocol and conventional care
timeFrame: 1 year
measure: Compare bowel function of pregnant women after Cesarean section between ERAS protocol and conventional care
timeFrame: 1 year
Other outcomes:
Locations:
city: Bangkok
country: Thailand
facility: Rajavithi hospital
Study officials:
References: